乳房切片器材市场－全球产业规模、份额、趋势、机会和预测，按类型、手术方式、应用、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球乳房切片器材市场规模为10.2亿美元，预计2030年将以6.89%的复合年增长率成长至15.2亿美元。乳房切片器械是用于从可疑乳房病灶中提取组织样本以进行确诊检查的专用仪器，涵盖了各种基于针头和真空辅助的系统，并可在影像引导下进行操作。全球乳房切片器材市场的主要驱动因素是乳癌发生率的上升、大众对早期检测意识的增强以及对微创诊断程序的日益青睐。

主要市场驱动因素

全球乳房切片设备市场受到全球乳癌发生率不断上升的显着影响，这导致对有效诊断解决方案的需求持续且迫切。发病率的上升使得更频繁、更准确的活检成为必要，以确诊并指导治疗策略。

主要市场挑战

先进的活检手术费用高昂，且依赖昂贵的影像技术，这严重阻碍了全球乳房活检设备市场的成长。这一经济障碍直接限制了市场扩张，限制了这些重要诊断工具的普及，尤其是在资源匮乏地区和预算紧张的医疗体系中。

主要市场趋势

将人工智慧和机器学习技术整合到乳房活检设备中，正在改变市场上的诊断准确性和工作流程效率。这些先进的计算方法增强了影像分析能力，帮助放射科医生更精确地识别细微异常并区分良性和恶性病变。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球乳房切片设备市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依类型（切片针、导引系统、切片台、定位导线、检测试剂盒、液体切片仪器、其他）
  • 依操作方法（针刺乳房切片、开放式手术乳房切片、液体乳房切片检查）
  • 按应用领域（早期癌症筛检、治疗方案选择、治疗监测、復发监测）
  • 按最终使用者（医院和手术中心、乳房护理中心、影像诊所和诊断中心）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美乳房切片设备市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲乳房切片设备市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区乳房切片设备市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲乳房切片设备市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲乳房切片设备市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球乳房切片设备市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Hologic Inc.
• Danaher Corporation
• Becton, Dickinson and Company
• Argon Medical Devices, Inc.
• Guardant Health, Inc.
• Merit Medical Systems, Inc.
• Neogenomics Laboratories, Inc.
• Sysmex Inostics, Inc.
• Sterylab SRL
• Bio-Rad Laboratories Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Breast Biopsy Devices Market, valued at USD 1.02 Billion in 2024, is projected to experience a CAGR of 6.89% to reach USD 1.52 Billion by 2030. Breast biopsy devices are specialized instruments utilized to extract tissue samples from suspicious breast lesions for definitive diagnostic examination, encompassing various needle-based and vacuum-assisted systems guided by imaging modalities. The global market for these devices is primarily driven by the increasing incidence of breast cancer, growing public awareness regarding early detection, and the expanding preference for minimally invasive diagnostic procedures.

Key Market Drivers

The global breast biopsy devices market is significantly influenced by the increasing worldwide prevalence of breast cancer, creating a sustained and urgent demand for effective diagnostic solutions. The rising incidence necessitates more frequent and accurate biopsies to confirm diagnoses and guide treatment strategies. According to the World Cancer Research Fund, in 2022, there were 2,296,840 new cases of breast cancer among women globally, underscoring the critical need for advanced diagnostic tools.

Key Market Challenges

The substantial cost associated with advanced biopsy procedures and their reliance on expensive imaging modalities represents a significant impediment to the growth of the Global Breast Biopsy Devices Market. This financial barrier directly restricts market expansion by limiting the adoption of these essential diagnostic tools, particularly within resource-limited regions and healthcare systems operating under stringent budgetary constraints. The high capital investment required for state-of-the-art imaging equipment, such as specialized mammography units or MRI systems, coupled with the ongoing expenses for maintenance and skilled personnel, renders these advanced diagnostic pathways largely inaccessible to a significant portion of the global healthcare infrastructure.

Key Market Trends

The integration of Artificial Intelligence and Machine Learning into breast biopsy devices is transforming diagnostic accuracy and workflow efficiency within the market. These advanced computational methods enhance image analysis, aiding radiologists in identifying subtle anomalies and differentiating between benign and malignant lesions with greater precision. According to a EuroAIM/EuSoMII 2024 survey among members of the European Society of Radiology, 48% of respondents were already utilizing AI or planning its adoption, with a predominant expected impact on breast imaging. This widespread acceptance underscores the growing confidence in AI's capabilities.

Key Market Players

• Hologic Inc.
• Danaher Corporation
• Becton, Dickinson and Company
• Argon Medical Devices, Inc.
• Guardant Health, Inc.
• Merit Medical Systems, Inc.
• Neogenomics Laboratories, Inc.
• Sysmex Inostics, Inc.
• Sterylab S.R.L.
• Bio-Rad Laboratories Inc.

Report Scope:

In this report, the Global Breast Biopsy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Breast Biopsy Devices Market, By Type:

• Biopsy Needles
• Guidance Systems
• Biopsy Tables
• Localization Wires
• Assay Kits
• Liquid Biopsy Instruments
• Others

Breast Biopsy Devices Market, By Procedure:

• Needle Breast Biopsy
• Open Surgical Breast Biopsy
• Liquid Breast Biopsy

Breast Biopsy Devices Market, By Application:

• Early Cancer Screening
• Therapy Selection
• Treatment Monitoring
• Recurrence Monitoring

Breast Biopsy Devices Market, By End User:

• Hospitals & Surgical Centers
• Breast Care Centers
• Imaging Clinics & Diagnostic Centers

Breast Biopsy Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Breast Biopsy Devices Market.

Available Customizations:

Global Breast Biopsy Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Breast Biopsy Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Others)
  • 5.2.2. By Procedure (Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy)
  • 5.2.3. By Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring)
  • 5.2.4. By End User (Hospitals & Surgical Centers, Breast Care Centers, Imaging Clinics & Diagnostic Centers)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Breast Biopsy Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Procedure
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Breast Biopsy Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Procedure
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Breast Biopsy Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Procedure
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Breast Biopsy Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Procedure
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Breast Biopsy Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Procedure
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Breast Biopsy Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Procedure
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Breast Biopsy Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Procedure
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Breast Biopsy Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Procedure
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Breast Biopsy Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Procedure
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Breast Biopsy Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Procedure
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Breast Biopsy Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Procedure
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Breast Biopsy Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Procedure
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Breast Biopsy Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Procedure
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Breast Biopsy Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Procedure
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Breast Biopsy Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Procedure
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Breast Biopsy Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Procedure
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Breast Biopsy Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Procedure
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Breast Biopsy Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Procedure
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Breast Biopsy Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Procedure
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Breast Biopsy Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Procedure
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Breast Biopsy Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Procedure
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Breast Biopsy Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Procedure
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Breast Biopsy Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Procedure
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Breast Biopsy Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Procedure
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Breast Biopsy Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Hologic Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Danaher Corporation
• 15.3. Becton, Dickinson and Company
• 15.4. Argon Medical Devices, Inc.
• 15.5. Guardant Health, Inc.
• 15.6. Merit Medical Systems, Inc.
• 15.7. Neogenomics Laboratories, Inc.
• 15.8. Sysmex Inostics, Inc.
• 15.9. Sterylab S.R.L.
• 15.10. Bio-Rad Laboratories Inc.

16. Strategic Recommendations

17. About Us & Disclaimer